Related Experiment Video
Updated: Aug 9, 2026

09:07
Direct Microbial Identification using An Automated Microbial Identification System to Facilitate the EUCAST RAST Method Without Mass Spectrometry
Published on: May 24, 2024
Prediction of bacteremia using TREAT, a computerized decision-support system
Mical Paul1, Steen Andreassen, Anders D Nielsen
1Department of Medicine E, Rabin Medical Center, Beilinson Campus, Petah-Tikva, Israel. pil1pel@zahav.net.il
Summary
The TREAT system accurately predicts bacteremia risk in sepsis patients, stratifying them into low, intermediate, and high-risk groups. This allows for identifying patients with suspected sepsis who may not require blood cultures.
Area of Science:
- Clinical decision support systems
- Infectious disease diagnostics
- Sepsis management
Background:
- Accurate prediction of bloodstream infections at sepsis onset is crucial for effective and economical patient management.
- Timely identification of bacteremia aids in appropriate treatment strategies and resource allocation.
Purpose of the Study:
- To evaluate the performance of the TREAT (TREATment) computerized decision-support system in predicting bacteremia in patients with suspected sepsis.
- To assess the system's ability to stratify patients into different risk categories for bacteremia.
Main Methods:
- The TREAT system, utilizing a causal probabilistic network, was prospectively implemented in two independent cohorts across Israel, Italy, and Germany.
- Data were collected at the time of blood culture sampling, and system performance was evaluated using receiver-operating characteristic (ROC) curves.
- Patients were stratified into low-, intermediate-, and high-risk groups based on TREAT's bacteremia prediction values.
Main Results:
- The TREAT system demonstrated good discriminative power, with an area under the ROC curve of 0.68 in the first cohort (790 patients) and 0.70 in the second cohort (1724 patients).
- Bacteremia prevalence varied significantly across risk groups: low-risk (1.3%-2.4%), intermediate-risk (12.8%-13.2%), and high-risk (28.1%-29.9%).
- The system's performance remained stable across the three international sites, and low-risk groups constituted 15%-17% of all patients.
Conclusions:
- The TREAT system effectively stratifies patients with suspected sepsis based on bacteremia risk using readily available clinical variables.
- The system's predictive accuracy is consistent across different geographical locations.
- TREAT can identify a low-risk patient cohort, potentially obviating the need for blood cultures and optimizing clinical workflows.